Synaxys Joins Neuroservices-Alliance

Neuroservices-Alliance is proud to welcome Synaxys, a French biotech specializing in the characterization of nervous system responses for nutraceutical, pharmaceutical, and veterinary applications. Through this partnership, Neuroservices-Alliance expands its service portfolio to include advanced human-based in vitro platforms, offering clients deeper translational insights and enhanced drug discovery support.

Enhanced Human-Relevance and Integrated Capabilities

  • Expertise in human iPSC-derived neuronal systems (5D-Brain platform)
  • Comprehensive evaluation of efficacy, neurotoxicity, and mechanism of action
  • Support for dose-effect studies, target identification, and biomarker discovery
  • Complementary to NSA’s in vivo and in vitro electrophysiology expertise

A Stronger Alliance for CNS and Pain Research

Together, Synaxys and Neuroservices-Alliance deliver a 360° functional characterization pipeline, bridging cell-based human models and animal electrophysiology studies to accelerate drug discovery and validation.